Literature DB >> 16061951

Apolipoprotein E inhibition of vascular hyperplasia and neointima formation requires inducible nitric oxide synthase.

Zachary W Q Moore1, David Y Hui.   

Abstract

Previous studies have shown apolipoprotein E (apoE) recruitment to medial layers of carotid arteries after vascular injury in vivo and apoE activation of inducible nitric oxide synthase (iNOS) in smooth muscle cells in vitro. This investigation explored the relationship between medial apoE recruitment and iNOS activation in protection against neointimal hyperplasia. ApoE was present in both neointimal-resistant C57BL/6 mice and neointimal-susceptible FVB/N mice 24 h after carotid denudation, but iNOS expression was observed only in the neointimal-resistant C57BL/6 mice. However, iNOS was not observed in apoE-defective C57BL/6 mice. In contrast, overexpression of apoE in FVB/N mice activated iNOS expression in the injured vessels, resulting in protection against neointimal hyperplasia. ApoE and iNOS were colocalized in the medial layer of neointimal-resistant mouse strains. Endothelial denudation of carotid arteries in the iNOS-deficient NOS2(-/-) mice did not increase neointimal hyperplasia but significantly increased medial thickness and area. The iNOS-specific inhibitor also abrogated the apoE protective effects on vascular response to injury in apoE-overexpressing FVB/N mice. Thus, injury-induced activation of iNOS requires apoE recruitment. Moreover, both apoE and iNOS are necessary for the suppression of cell proliferation, and apoE recruitment without iNOS expression resulted in medial hyperplasia without cell migration to the intima.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061951      PMCID: PMC1435725          DOI: 10.1194/jlr.M500177-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  30 in total

1.  Apolipoprotein E receptor binding versus heparan sulfate proteoglycan binding in its regulation of smooth muscle cell migration and proliferation.

Authors:  D K Swertfeger; D Y Hui
Journal:  J Biol Chem       Date:  2001-05-11       Impact factor: 5.157

2.  Decreased neointimal thickening after arterial wall injury in inducible nitric oxide synthase knockout mice.

Authors:  K Y Chyu; P Dimayuga; J Zhu; J Nilsson; S Kaul; P K Shah; B Cercek
Journal:  Circ Res       Date:  1999 Dec 3-17       Impact factor: 17.367

3.  Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice.

Authors:  B Zhu; D G Kuhel; D P Witte; D Y Hui
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

4.  Both apolipoprotein E and immune deficiency exacerbate neointimal hyperplasia after vascular injury in mice.

Authors:  Binghua Zhu; Catherine A Reardon; Godfrey S Getz; David Y Hui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-03-01       Impact factor: 8.311

5.  Innate diversity of adult human arterial smooth muscle cells: cloning of distinct subtypes from the internal thoracic artery.

Authors:  S Li; Y S Fan; L H Chow; C Van Den Diepstraten; E van Der Veer; S M Sims; J G Pickering
Journal:  Circ Res       Date:  2001-09-14       Impact factor: 17.367

6.  Low density lipoprotein receptor-related protein mediates apolipoprotein E inhibition of smooth muscle cell migration.

Authors:  Debi K Swertfeger; Guojun Bu; David Y Hui
Journal:  J Biol Chem       Date:  2001-12-05       Impact factor: 5.157

7.  Mice lacking inducible nitric oxide synthase develop spontaneous hypercholesterolaemia and aortic atheromas.

Authors:  M Ihrig; C A Dangler; J G Fox
Journal:  Atherosclerosis       Date:  2001-05       Impact factor: 5.162

8.  Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice.

Authors:  P J Kuhlencordt; J Chen; F Han; J Astern; P L Huang
Journal:  Circulation       Date:  2001-06-26       Impact factor: 29.690

9.  Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase.

Authors:  M Ishigami; D K Swertfeger; N A Granholm; D Y Hui
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

10.  Distinction in genetic determinants for injury-induced neointimal hyperplasia and diet-induced atherosclerosis in inbred mice.

Authors:  David G Kuhel; Binghua Zhu; David P Witte; David Y Hui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-06-01       Impact factor: 8.311

View more
  12 in total

1.  Apolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stress.

Authors:  James G Cash; David G Kuhel; Joshua E Basford; Anja Jaeschke; Tapan K Chatterjee; Neal L Weintraub; David Y Hui
Journal:  J Biol Chem       Date:  2012-06-23       Impact factor: 5.157

2.  Apolipoprotein E inhibits toll-like receptor (TLR)-3- and TLR-4-mediated macrophage activation through distinct mechanisms.

Authors:  Yanjuan Zhu; Ahmer Kodvawala; David Y Hui
Journal:  Biochem J       Date:  2010-04-28       Impact factor: 3.857

3.  apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.

Authors:  Panagiotis Fotakis; Alexander Vezeridis; Ioannis Dafnis; Angeliki Chroni; Dimitris Kardassis; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2014-04-28       Impact factor: 5.922

4.  High glucose oxidizes SERCA cysteine-674 and prevents inhibition by nitric oxide of smooth muscle cell migration.

Authors:  Xiaoyong Tong; Jia Ying; David R Pimentel; Mario Trucillo; Takeshi Adachi; Richard A Cohen
Journal:  J Mol Cell Cardiol       Date:  2007-11-12       Impact factor: 5.000

Review 5.  Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases.

Authors:  Roman Ginnan; Benjamin J Guikema; Katharine E Halligan; Harold A Singer; David Jourd'heuil
Journal:  Free Radic Biol Med       Date:  2008-01-22       Impact factor: 7.376

Review 6.  Intimal hyperplasia in murine models.

Authors:  David Y Hui
Journal:  Curr Drug Targets       Date:  2008-03       Impact factor: 3.465

7.  Up-regulation of apolipoprotein E by leptin in the hypothalamus of mice and rats.

Authors:  Ling Shen; Patrick Tso; David Q-H Wang; Stephen C Woods; W Sean Davidson; Randall Sakai; Min Liu
Journal:  Physiol Behav       Date:  2009-05-28

8.  Transplanted perivascular adipose tissue accelerates injury-induced neointimal hyperplasia: role of monocyte chemoattractant protein-1.

Authors:  David Manka; Tapan K Chatterjee; Lynn L Stoll; Joshua E Basford; Eddy S Konaniah; Ramprasad Srinivasan; Vladimir Y Bogdanov; Yaoliang Tang; Andra L Blomkalns; David Y Hui; Neal L Weintraub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-06-19       Impact factor: 8.311

9.  Kalirin promotes neointimal hyperplasia by activating Rac in smooth muscle cells.

Authors:  Jiao-Hui Wu; Alexander C Fanaroff; Krishn C Sharma; Liisa S Smith; Leigh Brian; Betty A Eipper; Richard E Mains; Neil J Freedman; Lisheng Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

10.  Changing topographic Hox expression in blood vessels results in regionally distinct vessel wall remodeling.

Authors:  Nathanael D Pruett; Zoltan Hajdu; Jing Zhang; Richard P Visconti; Michael J Kern; Deneen M Wellik; Mark W Majesky; Alexander Awgulewitsch
Journal:  Biol Open       Date:  2012-03-20       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.